SGLT2 inhibitor
Sodium-glucose cotransporter-2 inhibitor (empagliflozin, dapagliflozin, canagliflozin) that blocks renal glucose reabsorption. Provides cardiovascular and renal protection independent of glucose lowering.
Study diabetes lessonsPractice questions